Welcome Prof. Xiangyang Shi as Founding Editor-in-Chief of Nanomedicine Therapeutics
OAE's newly launched international, peer-reviewed, open access journal, Nanomedicine Therapeutics, is pleased to announce the appointment of Prof. Xiangyang Shi from Donghua University, Shanghai, China, as its Founding Editor-in-Chief.
About the Journal
Nanomedicine Therapeutics is dedicated to publishing high-quality research articles and reviews at the forefront of therapeutic nanomedicine. The journal aims to provide a global platform for innovative studies that bridge nanoscale material design with clinical therapeutic applications, promoting the translation of nanomedical discoveries from laboratory research into clinical practice.
Nanomedicine Therapeutics focuses on interdisciplinary research that integrates chemistry, materials science, biology, engineering, and medicine to develop advanced nanosystems for disease diagnosis and treatment.
The journal covers a wide range of topics in therapeutic nanomedicine, including nanocarrier-based drug delivery, targeted and stimuli-responsive nanotherapeutics, theranostics, nanomaterials for immunotherapy and vaccines, regenerative medicine, strategies to overcome biological barriers, biosafety considerations, and the clinical translation of nanomedicine, as well as emerging therapeutic modalities such as photothermal, photodynamic, and sonodynamic therapies.
About Prof. Xiangyang Shi
Prof. Xiangyang Shi is a Changjiang Distinguished Professor and a recipient of the National Science Fund for Distinguished Young Scholars in China. His pioneering work in nanomedicine, biomaterials, and targeted drug delivery has significantly advanced the development of nanotherapeutic strategies for disease treatment.
Under the leadership of Prof. Shi, Nanomedicine Therapeutics aims to become a valuable platform for disseminating innovative research and promoting the advancement and clinical translation of nanomedicine worldwide.
The Editorial Office of Nanomedicine Therapeutics warmly welcomes Prof. Shi as the Founding Editor-in-Chief. We sincerely appreciate his dedication and support. With his leadership and through the collaborative efforts of the Editorial Board and the Editorial Office, we are confident that the journal will embark on an exciting era of growth and scientific excellence. We warmly invite researchers, clinicians, and scientists from around the world to contribute their latest findings, share innovative ideas, and join us in building a vibrant academic community dedicated to advancing nanomedicine.
Editor: Xin Chen
Language Editor: Catherine Yang
Production Editor: Ting Xu
Respectfully Submitted by the Editorial Office of Nanomedicine Therapeutics
